Cancer Treatment Centers of America (CTCA): Business Overview, Financials & Competitive Analysis

Cancer Treatment Centers of America (CTCA) Overview

Cancer Treatment Centers of America (CTCA) is a national network of comprehensive cancer care and research centers and outpatient care centers serving cancer patients throughout the United States. It was acquired by City of Hope in 2022, and its hospitals and outpatient locations were rebranded in 2023, now operating as a non-profit organization under the parent name City of Hope. CTCA operates as a subsidiary focused on delivering integrated oncology services with direct patient engagement.

Strategic Profile

Founded in 1988 on a personalized, patient-centered approach to cancer care, CTCA is dedicated to tailoring a combination of cancer treatments to the needs of each individual patient. CTCA is a part of City of Hope, a National Cancer Institute-designated comprehensive cancer center and a founding member of the National Comprehensive Cancer Network. As a City of Hope subsidiary, CTCA leverages its parent's research capabilities and clinical expertise while maintaining its specialized oncology focus across multiple states.

Competitive Landscape

CTCA competes in the specialized oncology hospital market against other comprehensive cancer centers and multi-hospital health systems offering integrated cancer services. Key competitors include academic medical centers with cancer institutes, national cancer center networks, and regional oncology-focused providers. CTCA's differentiation lies in its direct-to-consumer brand presence, integrative treatment approach, and focused cancer specialization rather than general health system offerings.

Industry Context

Cancer Treatment Centers of America (CTCA) operates in Hospitals and Healthcare Facilities.

Key facts

Founded: 1988 · Headquarters: Boca Raton, US · Employees: 11,000 (combined with City of Hope operations as of 2022)